BONITA SPRINGS, FL – July 20, 2026 – Optivate, a leading all-in-one AI-powered platform built exclusively for ophthalmology and optometry practices, today announced the opening of a new corporate office in Palm Beach Gardens, Florida. The new location will serve as Optivate’s corporate headquarters, complementing the company’s existing office in Bonita Springs, FL.

The new office is located at 4440 PGA Blvd, Suite 600, Palm Beach Gardens, FL 33410. The expansion reflects Optivate’s continued growth and its commitment to building a strong presence in Florida as the company scales its platform, which spans EHR, Practice Management, Patient Engagement, Revenue Cycle Management, Optical, and ASC solutions for eye care providers nationwide.

“I live right here in Jupiter, just minutes from our new office, and I couldn’t be more excited to plant our flag in Palm Beach Gardens,” said Brad Caldwell, CEO of Optivate. “This market gives us access to incredible talent and puts our leadership team in a great position to keep building the company. Bonita Springs remains a key part of who we are, and this new office is the next step forward for Optivate.”

Optivate will continue to maintain a Bonita Springs office alongside the new Palm Beach Gardens location as part of its broader operational footprint in Florida.

About Optivate

Optivate is an all-in-one AI-powered platform built exclusively for ophthalmology and optometry practices, offering EHR, Practice Management, Patient Engagement, Revenue Cycle Management, Optical, and ASC solutions in a single, integrated platform. Optivate’s corporate headquarters is located at 4440 PGA Blvd, Suite 600, Palm Beach Gardens, FL 33410, with an additional office at Bonita Springs, FL.

If you have been using EyeMD EMR Healthcare Systems or have been evaluating it as your next ophthalmology EHR platform, you may have noticed something new: the name has changed. EyeMD EMR Healthcare Systems is now Optivate. And while a rebrand might initially raise questions about continuity, service disruption, or strategic direction, this transition carries a clear message: the platform is not just getting a new name. It is making a commitment.

This post unpacks exactly what changed, what did not, and why this ophthalmology EHR rebrand is worth paying attention to if you are an ophthalmologist or practice owner evaluating your technology options in 2026.

Rebrands happen constantly across the healthcare technology industry. Many of them are cosmetic: a new color palette, a refreshed website, a tagline update. Ophthalmology practices have learned to look past surface-level changes and ask harder questions. Does the system still support my subspecialty workflows? Is the team behind the platform the same one that earned my trust? And does the new identity reflect something real about where the product is heading?

In the case of EyeMD EMR becoming Optivate, the answers to those questions point toward substance.

On September 17, 2025, EyeMD EMR Healthcare Systems formally announced its rebrand to Optivate. According to the official announcement on Globe Newswire, the rebrand reflects the company’s evolution beyond its original identity as it continues to streamline workflows, empower providers, and prepare practices for the future of healthcare technology. The leadership team, platform, services, and deep dedication to ophthalmology remain intact.

Key Point: The rebrand is not a pivot away from ophthalmology. It is a signal that the company’s commitment to the specialty is only deepening.

EyeMD EMR was not born from a generalist healthcare software company that decided to add an ophthalmology module. It was built from the ground up by people who understood the clinical complexity of eye care and recognized that ophthalmology has a fundamentally different workflow than internal medicine, cardiology, or primary care.

Ophthalmology is image-intensive. A glaucoma exam generates IOP readings, visual fields, and OCT imaging. A cataract evaluation requires precise biometry data. A retina consult involves high-resolution fundus photography and fluorescein angiography. These clinical realities require an EHR designed around them, not one that treats them as exceptions to a general template.

EyeMD EMR was recognized for getting that right. In February 2024, the company received the Best in KLAS Award for Ophthalmology EMR from KLAS Research, an impartial research organization widely respected across the healthcare technology industry. That recognition reflected years of building a platform around subspecialty charting, diagnostic integration, and operational clarity specific to eye care.

That foundation is what Optivate is building on, not replacing.

The word “Optivate” combines optimize and elevate. Optimize care. Elevate what matters. That tagline is not marketing language for its own sake. It describes the product philosophy that has driven the platform’s development: remove the friction, streamline the workflow, and give providers back the time and mental clarity to focus on their patients.

Earlier in 2025, EyeMD EMR announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on scaling software and technology businesses. That investment marked the beginning of an accelerated growth chapter, one in which the product’s reach, innovation capacity, and market presence would all expand.

A new name was a natural part of that chapter. EyeMD EMR Healthcare Systems accurately described what the product was in its early years. Optivate describes what the company is now and where it is going: a fully integrated, specialty-exclusive platform built not just for EMR, but for every clinical and operational layer of an ophthalmology practice.

If you want a deeper comparison of what separates a purpose-built ophthalmology EHR from a generalist system, read our breakdown of ophthalmology vs. multi-specialty EHR.

Optivate is not a single product. It is a connected suite of specialty-built solutions designed to cover the full operational and clinical scope of an ophthalmology practice. The platform includes seven integrated solutions:

For a full breakdown of how each solution is built and why specialty-only wins, download The Ophthalmology Practice Technology Guide 2026.

What connects all seven solutions is that none of them were designed with any other specialty in mind. Every feature, every workflow template, every update to the platform has ophthalmology as the only use case. That is a structural advantage that generalist or multi-specialty platforms cannot replicate.

If you are a current EyeMD EMR client, the official rebrand announcement makes clear that no action is required on your part. You continue using the same platform, the same login credentials, and the same support team. Billing rates and processes remain unchanged. Invoices will gradually carry the Optivate name as the transition completes, but the service relationship is uninterrupted.

That continuity matters because changing EHR systems is one of the most disruptive decisions a practice can make. When the people, the product, and the underlying technology remain in place, a rebrand becomes an opportunity rather than a risk.

The Optivate team, leadership, and development roadmap reflect the same specialty-exclusive focus that defined EyeMD EMR. What changes is the scope of ambition: a broader platform vision, expanded innovation capacity backed by new growth investment, and a brand identity that finally matches the depth of what the product delivers.

See The Optivate Platform at a Glance for a quick visual overview of all 7 solutions and how they connect.

The timing of this rebrand is not accidental. The ophthalmology EHR market is growing rapidly. One market report projects the segment will reach $2.5 billion by 2033, growing at a compound annual growth rate of approximately 8.8%. Aging populations, rising rates of diabetic retinopathy, glaucoma, and macular degeneration, and increasing adoption of digital health tools across the specialty are all contributing to that trajectory.

In that environment, the distinction between a platform built exclusively for ophthalmology and one that has added an ophthalmology module to serve a dozen other specialties becomes increasingly consequential.

Consider the competitive landscape that Optivate operates within. ModMed serves over 11 specialties. Nextech serves five. NextGen serves more than 26. Each of those companies distributes its development resources, product roadmap decisions, and customer support capacity across multiple specialty markets. When an ophthalmology-specific feature needs an update or a new subspecialty workflow needs to be built, it competes for priority against dermatology, orthopedics, and urology on the same product backlog.

Optivate does not have that constraint. Every engineering hour, every product decision, every support resource is directed at one specialty. That is what “specialty-only” means in practice, and it is a structural advantage that compounds overtime.

If you are an ophthalmologist or practice owner currently evaluating EHR platforms, the rebrand from EyeMD EMR to Optivate changes the context of that evaluation.

It confirms that the platform’s trajectory is one of expansion, not contraction. New investment capital, a refreshed product identity, and a full suite of integrated solutions signal a company in growth mode. For practices making a long-term technology commitment, that trajectory matters as much as the current feature set.

It also reframes the question you should be asking your EHR vendor. The right question is not only “Does this system have ophthalmology templates?” The more meaningful question is: “Was this system designed from the beginning for ophthalmology, and is every future update going to reflect the needs of ophthalmology practices specifically?”

For practices that have spent years working around generic EHR systems adapted for eye care, the distinction is not abstract. It shows up in charting time, in diagnostic image integration, in the accuracy of ophthalmology billing codes, and in the responsiveness of a support team that understands your clinical and operational world.

For Independent Practices: Optivate offers the operational depth of an enterprise platform without the complexity. The two-week average go-live time and US-based support team are designed for practices without large IT departments.

For Growing Groups: The platform’s flexible deployment options (cloud, on-premises, or hybrid) and multi-location scalability are built to grow alongside your group without requiring system changes at each growth stage.

One of the clearest signals of Optivate’s direction came from the AAO 2025 conference, where the platform introduced its new brand identity and demonstrated AI-enabled clinical workflows to a broadly positive reception. Attendees and existing customers described the rebrand as “modern,” “professional,” and representing “the next era of intelligent ophthalmology technology.”

The innovation areas Optivate is investing in include:

These are not features that can be built equally well by a platform serving 26 specialties. They reflect the focused investment that comes from having a single specialty as the only customer.

The EyeMD EMR to Optivate transition is not a story about a company changing direction. It is a story about a company doubling down in the direction it has always taken: building the best possible technology for ophthalmology, and only for ophthalmology.

The new name carries the weight of that commitment. “Optimize care. Elevate what matters.” That is the promise behind the platform, and it is the same promise that earned EyeMD EMR a Best in KLAS designation, a loyal customer base, and the confidence of growth investors who see the specialty-exclusive EHR space as one of the most compelling opportunities in healthcare technology.

For ophthalmology practices deciding where to place their technology trust, the Optivate rebrand offers a clear answer to the question of alignment: this is a company that has made ophthalmology its only focus and intends to keep it that way.

Ready to See What Optivate Looks like for Your Practice?

Whether you are an existing EyeMD EMR client curious about what is next or a practice evaluating your first specialty-built EHR, Optivate is built for where ophthalmology is heading. Request a personalized platform walkthrough and see the specialty difference for yourself.

Schedule Your Optivate Platform Walkthrough

1. What is the difference between EyeMD EMR and Optivate?

Optivate is the new name for EyeMD EMR Healthcare Systems, announced in September 2025. The platform, team, and core technology remain unchanged. The rebrand reflects an expanded product vision and platform identity, with Optivate serving as the unified name for the full suite of specialty-built ophthalmology solutions formerly offered under the EyeMD EMR brand.

2. Do I need to do anything if I am a current EyeMD EMR client?

No action is required from current clients. You continue using the same platform, login credentials, and services. Billing processes remain unchanged, and your support team is the same. Invoices will gradually reflect the Optivate name as the brand transition completes.

3. Why did EyeMD EMR rebrand to Optivate?

The rebrand reflects the company’s evolution beyond its original identity. With expanded platform capabilities (including seven integrated solutions), growth investment from Performant Capital, and a broader product vision, the Optivate name better represents the full scope of what the company offers ophthalmology practices today and where the platform is headed.

4. Is Optivate still exclusively focused on ophthalmology?

Yes. Optivate is built exclusively for ophthalmology and eye care. Unlike competitors that serve 5, 11, or 26+ specialties, Optivate’s entire platform, development roadmap, and support infrastructure is dedicated to one specialty. That focus is a core differentiator and remains central to the brand’s identity.

5. What solutions does Optivate offer?

Optivate offers seven integrated solutions designed specifically for ophthalmology: EHR, Practice Management, Revenue Cycle Management, Patient Engagement, Image Management, Optical Management, and an Ambulatory Surgery Center (ASC) module. All seven are built exclusively for ophthalmology.

6. Did EyeMD EMR win any awards before rebranding?

Yes. In February 2024, EyeMD EMR received the Best in KLAS Award for Ophthalmology EMR from KLAS Research, an impartial healthcare technology research organization. This recognition reflected strong performance across ease of use, imaging, documentation, and support, as rated by ophthalmology practices.

7. What is the Optivate Patient Engagement system?

Patient Engagement is Optivate’s third-generation platform, launched in 2023. It enables ophthalmology practices to interact with patients digitally outside the clinical setting, including digital intake, appointment management, and post-visit communication. It is designed specifically for eye care workflows.

8. How does Optivate compare to ModMed, Nextech, or NextGen for ophthalmology?

The key distinction is specialty exclusivity. ModMed serves 11+ specialties, Nextech serves 5, and NextGen serves 26+. Optivate serves one: ophthalmology. That means every feature, update, and support resource is directed at the needs of eye care practices specifically, without competing priorities across other specialties.

9. Does Optivate support cloud-based and on-premises deployment?

Yes. Optivate offers flexible deployment options including cloud, on-premises, and hybrid configurations. This flexibility allows practices to choose the model that fits their IT infrastructure, data governance preferences, and operational requirements.

10. What is the Optivate platform vision for 2026 and beyond?

Optivate’s roadmap includes embedded AI automation for clinical documentation, browser-based platform access, expanded ASC EMR capabilities, deeper HL7 integration, and continued development of the patient engagement system. These innovations are developed exclusively for ophthalmology, informed by clinical feedback from eye care practices.

Rebrand builds on EyeMD EMR’s legacy while positioning Optivate for future-ready innovation and growth.

BONITA SPRINGS, Fla. – September 17, 2025 – EyeMD EMR Healthcare Systems and its subsidiary, Abillifeye (collectively EyeMD EMR), a trusted provider of specialty-built healthcare technology software and medical billing services for ophthalmology practices and eye care specialists, today announced it is rebranding as Optivate.

The new brand reflects the company’s evolution beyond its original identity, as it continues to simplify workflows, empower providers, and prepare practices for the future of healthcare technology.

“This rebrand represents an exciting new chapter for our company. As EyeMD EMR, we built a strong reputation as a trusted partner for eye care providers. With Optivate, we’re building on that legacy while accelerating innovation and delivering smarter solutions that make complexity feel simple. Our focus is clear: to streamline workflows, empower providers, and elevate patient outcomes — ensuring every ophthalmology practice can thrive in an increasingly complex healthcare environment,” said Abdiel Marin, CEO of Optivate.

Optivate (formerly EyeMD EMR Healthcare Systems and its subsidiary, Abillifeye) delivers specialty-built software and solutions that help ophthalmology practices cut through complexity and focus on care. From EMR and PM to RCM and patient engagement, Optivate provides clarity that powers confident care. Built on best-in-class customer support and an exclusive long-standing dedication to eye care, Optivate is the partner of choice for eye care providers seeking to remove friction, empower care teams, and elevate patient outcomes.

CHICAGO, IL – April 24, 2025 – EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses.

Performant’s investment marks the next step in EyeMD EMR’s growth journey, supporting the Company as it continues to expand its platform and deepen its focus on serving ophthalmologists. EyeMD EMR’s leadership team will remain at the helm, committed to driving the mission of innovating and providing specialty-focused solutions.

“EyeMD EMR was founded with a singular focus to serve ophthalmologists with software designed specifically for their needs,” said Abdiel Marin, Founder and CEO of EyeMD EMR. “This founding vision continues to guide us, and in Performant, we have found a partner who not only shares our mission but also aligns with our vision. Their track record of scaling businesses and their alignment with our vision made this a natural fit, and we are thrilled and excited to partner with Performant to accelerate growth and innovations, providing even greater value to our customers.“

“Ophthalmology is a field with evolving and increasingly complex needs. This investment will advance our core offerings, including EMR, PM, Axon patient engagement, and RCM services, while also allowing us to stay at the forefront of innovations. We are excited to work with Performant to expand the capabilities of our platform while continuing to deliver best-in-class customer support,” said Gus Savloff, Chief Growth Officer of EyeMD EMR.

“We are incredibly excited about the future and look forward to collaborating with Performant to further enhance our technical platforms. Our continued focus is on building tools that reduce practices’ administrative burdens while maximizing reimbursement, ultimately simplifying workflows for ophthalmologists so they can concentrate on delivering exceptional patient care,” said Jessica Marin, President of Abillifeye, the RCM and billing division of EyeMD EMR.

“We couldn’t be more excited to join forces with EyeMD EMR,” said Michael Ciaglia, Partner at Performant Capital. “This investment underscores our commitment to partnering with dynamic and mission-critical companies for whom Performant’s unique blend of operational, technology, and investing expertise can unlock significant growth. As the leading EMR built exclusively for ophthalmologists, their unwavering commitment to the specialty and the strength of their purpose-built platform make them a truly special company, and we’re excited to work together and support the next chapter of growth and success.”

“At Performant, we look to back teams solving important problems with focus and clarity,” said James Won, Vice President at Performant Capital. “EyeMD EMR has done exactly that, developing a solution tailored to the unique clinical and operational needs of eye care professionals. We’re thrilled to partner with the team, and we look forward to investing even more in product innovation, user experience, and workflow efficiency to continue enabling our customers to deliver exceptional patient outcomes.”

Founded in 2009, EyeMD EMR was built from the ground up in collaboration with practicing, board-certified ophthalmologists, ensuring every element of the platform reflects the real-world clinical and workflow needs of the specialty. This strong alignment with the needs of eye care providers earned the Company the 2024 Best in KLAS Award for Ophthalmology EMR, further validating the strength of its core EMR platform and its broader suite of solutions, including the Company’s practice management and patient engagement software, and revenue cycle management and billing services.

The EyeMD EMR leadership team, in partnership with Performant Capital, is committed to setting a new standard of excellence in ophthalmology technology and advancing the future of care for eye care professionals and their patients.

About EyeMD EMR
EyeMD EMR specializes in developing and supplying electronic medical records software for ophthalmologists and related sub-specialties, including retina, cornea, pediatric ophthalmology, and glaucoma. The company’s solutions, which include practice management, patient engagement, image management, and RCM and billing services are designed to streamline clinical documentation workflows and improve daily practice efficiencies for eye care professionals. More information about EyeMD EMR can be found at www.eyemdemr.com.

About Performant Capital
Performant Capital is a Chicago-based private equity firm focused on investments in technology-driven companies. Performant acquires businesses across SaaS, technology-enabled services, and data intelligence products and services. With over 50 years of collective investing and operating experience in these sectors, Performant’s principals seek opportunities where its depth of investing, operating expertise, and partner network can materially impact performance. More information about Performant Capital can be found at www.performantcapital.com.

BONITA SPRINGS, Fla., Feb. 7, 2024 — EyeMD EMR, a leading provider of clinical software solutions designed specifically for eye care, announced its receipt of the prestigious Best in KLAS Award for Ophthalmology EMR from KLAS Research, an impartial research firm used worldwide by providers and payers. This esteemed accolade underscores EyeMD EMR’s commitment to innovation, excellence, and unparalleled service within the healthcare technology sector.

The 2024 Best in KLAS Awards recognizes healthcare technology companies that consistently demonstrate excellence in meeting the needs and expectations of healthcare providers. KLAS Research evaluates products based on feedback from healthcare professionals, ensuring that the awards reflect real-world experiences and outcomes.

“We are deeply honored to receive this award,” said Abdiel Marin, CEO of EyeMD EMR. “This award proves that we consistently deliver on the unique needs of ophthalmology practices in a way that remains unrivaled. Every User Satisfaction Survey conducted in ophthalmology, including those sponsored by two physician advocacy groups, consistently shows our users having the highest levels of satisfaction. I’m not aware of any other EHR company in any specialty that has achieved this level of user survey corroboration. While our technology is outstanding, this award is a testament to the incredible dedication of our staff, who share our core values and strive to deliver experiences that lead to outcomes like this. I feel privileged to lead such an exceptional group of individuals and look forward to seeing them grow with us.”

EyeMD EMR stands out in the healthcare technology landscape for its intuitive design, comprehensive features, and seamless integration capabilities. The platform empowers ophthalmology practices to streamline their workflows, enhance patient care, and deliver exceptional outcomes.

“We are thrilled to be recognized as the Best in KLAS for Ophthalmology EMR. This recognition not only celebrates our excellence in EMR but also underscores the strength of our full suite of products, including Practice Management and Axon Patient Engagement. As we celebrate this achievement, we are even more excited about the future. This recognition fuels our passion for continuous improvement and growth. We look forward to expanding our ophthalmic offerings and delivering even greater value to our clients in the years ahead.” – Gus Savloff, CGO of EyeMD EMR.”

For more information about EyeMD EMR and its award-winning solutions, visit eyemdemr.com.

To get a copy of the 2024 Best in KLAS Awards: Software and Services report visit: 
https://klasresearch.com/report/2024-best-in-klas-awards-software-and-services/3413

About EyeMD EMR:

EyeMD EMR offers innovative clinical software solutions designed specifically for eye care that create healthcare efficiencies, increase patient satisfaction, and improve quality of care. EyeMD EMR has achieved unprecedented levels of EHR user satisfaction corroborated by user satisfaction surveys performed by KLAS research and physician associations including AAO/AAOE, and ASCRS/ASOA. EyeMD EMR is a distinguished 3-time honoree of the prestigious “America’s Fastest Growing Companies” award by Inc. 5000. For more information, visit www.eyemdemr.com or call (877) 2 EYE EMR.

About KLAS Research:

KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at klasresearch.com.